Erik Boot

Erik Boot

UNVERIFIED PROFILE

Are you Erik Boot?   Register this Author

Register author
Erik Boot

Erik Boot

Publications by authors named "Erik Boot"

Are you Erik Boot?   Register this Author

43Publications

1085Reads

34Profile Views

Neurobiological perspective of 22q11.2 deletion syndrome.

Lancet Psychiatry 2019 Aug 5. Epub 2019 Aug 5.

Department of Psychiatry & Neuropsychology, Maastricht University, Maastricht, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(19)30076-8DOI Listing
August 2019

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.

Am J Med Genet A 2019 Aug 13. Epub 2019 Aug 13.

Department of Psychiatry, University Medical Center Utrecht, Utrecht University & University Medical Center Utrecht Brain Center, Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.61324DOI Listing
August 2019

A genetic model for multimorbidity in young adults.

Genet Med 2019 Jul 31. Epub 2019 Jul 31.

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0603-1DOI Listing
July 2019

All-cause mortality and survival in adults with 22q11.2 deletion syndrome.

Genet Med 2019 Apr 5. Epub 2019 Apr 5.

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0509-yDOI Listing
April 2019

22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

Mov Disord Clin Pract 2019 Jan 9;6(1):11-16. Epub 2018 Nov 9.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease Research Toronto Western Hospital and University of Toronto Toronto Ontario Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335527PMC
January 2019

Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Am J Med Genet A 2018 10 19;176(10):2146-2159. Epub 2018 May 19.

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209527PMC
October 2018

Non-pharmacological treatment of psychiatric disorders in individuals with 22q11.2 deletion syndrome; a systematic review.

Am J Med Genet A 2018 08 24;176(8):1742-1747. Epub 2018 Jan 24.

The Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057848PMC
August 2018

A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson's disease and schizophrenia.

Sci Adv 2018 08 15;4(8):eaar6637. Epub 2018 Aug 15.

Department of Research and Drug Discovery, Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciadv.aar6637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093626PMC
August 2018

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Neurology 2018 06 11;90(23):e2059-e2067. Epub 2018 May 11.

From The Dalglish Family 22q Clinic for Adults and Department of Psychiatry (E.B., A.M.F., A.S.B.), Toronto General Research Institute (A.S.B.), and Division of Cardiology, Department of Medicine (A.S.B.), University Health Network, Toronto, Canada; De Hartekamp Groep (E.B.), Centre for People with Intellectual Disability, Haarlem; Department of Nuclear Medicine (E.B., J.B.), Academic Medical Center, Amsterdam, the Netherlands; Clinical Genetics Research Program and Campbell Family Mental Health Research Institute (N.J.B., A.M.F., A.S.B.), Centre for Addiction and Mental Health, Toronto; Institute of Medical Science (N.J.B., M.M., A.E.L., A.S.B.), Division of Neurology, Department of Medicine (C.M., M.M., A.E.L.), and Department of Psychiatry (A.S.B.), University of Toronto; Deer Lodge Movement Disorders Centre (S.U.); Section of Neurology (S.U.), Division of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease Research (C.M., A.E.L.), Toronto Western Hospital and University of Toronto, Canada; Department of Molecular Neuroscience (K.Y.M., N.W.W.), UCL Institute of Neurology, London, UK; Department of Neurology (S.K.), Kansai Medical University, Osaka, Japan; Department of Neurology (M.J.B.), University of Virginia School of Medicine, Charlottesville; Medical Genetics Unit (P.P.), Perugia University Hospital, Italy; Department of Neurology (B.D.B.), University of Colorado Anschutz Medical Campus, Aurora; Neurology Section (B.D.B.), VA Eastern Colorado Health Care System, Denver; Cognitive & Movement Disorders Clinic and Hurvitz Brain Sciences Research Program (M.M.), Sunnybrook Health Sciences Centre, Toronto, Canada; Departments of Clinical Neurosciences (Movement Disorders) (B.D.) and Genetics (Neurogenetics) (K.N.), Timone University Hospital (AP-HM), Provence-Alpes-Côte d'Azur; Aix-Marseille University (B.D., K.N.), Marseille; Department of Genetics (Neurogenetics) (P.C., A.J.), Pitié-Salpêtrière University Hospital; Sorbonne University (P.C., A.J.), Paris; Department of Neurosciences (Movement Disorders) (E.M.), Lille University Hospital; Lille University (E.M.); Department of Neurology (Movement Disorders) (T.D.), Pierre Wertheimer University Hospital, Lyon; Marc Jeannerod Center for Cognitive Neurosciences (T.D.), Lyon-1 University; Department of Neurology (Movement Disorders) and Clinical Investigation Center (Clinical and Experimental Neurosciences) (O.C.), Poitiers University Hospital; Department of Neurology (Movement Disorders) (S.D.), Rennes University Hospital; Rennes-1 University (S.D.); Department of Clinical Neurosciences (Movement Disorders) (M.B.), Nice University Hospital, France; Department of Psychiatry (A.M.F.), Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, the Netherlands; Center for Human Genetics (E.V., A.S., A.V.), University Hospital Leuven; Department of Human Genetics (A.S.), KU Leuven, Belgium; Department of Neurology (A.P.), University of Munich, Germany; Scientific and Technological Coordination Unit of the ANLIS Directorate (C.P.), National Administration of Laboratories and Institutes of Health, Argentina; Department of Neurodegenerative Diseases (T.G.), Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.); Department of Neurology (K.C.), AZ Turnhout, Antwerp, Belgium; Neurology Unit and Stroke Center (F.B.), Hôpital Foch, Suresnes, France; Movement Disorder Division (K.M.), Johns Hopkins University, Baltimore, MD; and Psychological Medicine and Clinical Neurosciences (N.M.W.), MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993183PMC
June 2018

Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome.

Am J Med Genet A 2018 04;176(4):936-944

The Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38645DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873609PMC
April 2018

Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.

Psychiatry Res Neuroimaging 2018 02 21;272:65-70. Epub 2017 Nov 21.

Maastricht University, Department of Psychiatry and Psychology, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2017.11.014DOI Listing
February 2018

Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.

Am J Psychiatry 2017 11 28;174(11):1054-1063. Epub 2017 Jul 28.

From the Dalglish Family 22q Clinic, Department of Psychiatry, University Health Network, Toronto; the Department of Psychiatry and Toronto General Research Institute, University Health Network, Toronto; the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto; the Department of Psychiatry, University of Toronto, Toronto; the Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto; the Centre for Applied Genomics and Program in Genetics and Genome Biology, the Hospital for Sick Children, Toronto; the Medical Genetics Residency Training Program, University of Toronto, Toronto; the Department of Psychiatry and Psychology, Maastricht University, Maastricht, the Netherlands; the Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia; the Departments of Pediatrics and of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Centre for Human Genetics, University of Leuven (KU Leuven), Leuven, Belgium; the Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, Wales; the Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin; the Department of Child and Adolescent Psychiatry, King's College London; the Department of Psychiatry, Tel Aviv University, Tel Aviv, Israel; the Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles; Office Médico-Pédagogique Research Unit, Department of Psychiatry, University of Geneva School of Medicine, Geneva; the Department of Psychiatry and Behavioral Sciences, Upstate Medical University, State University of New York, Syracuse; Département de Génétique Médicale, Centre Hospitalier Universitaire de Marseille - Hôpital de la Timone, Marseilles, France; the Department of Pediatrics, Duke University, Durham, N.C.; the Department of Psychology, University of Newcastle, Newcastle, Australia; the Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands; the Department of Human Genetics, Emory University, Atlanta; Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile; the Department of Psychiatry and Behavioral Sciences, UC Davis, Sacramento, Calif.; Molecular Genetics and McLaughlin Centre, and Laboratory Medicine and Pathobiology, University of Toronto, Toronto; the Department of Genetics, Albert Einstein College of Medicine, Bronx, N.Y.; and Genome Diagnostics, Department of Paediatric Laboratory Medicine, the Hospital for Sick Children, Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2017.16121417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665703PMC
November 2017

Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.

Curr Opin Psychiatry 2017 May;30(3):191-196

aDepartment of Psychiatry, University of Toronto bClinical Genetics Research Program, Centre for Addiction and Mental Health cThe Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, Toronto General Hospital dDepartment of Psychiatry, and Division of Cardiology, Department of Medicine, University Health Network eToronto General Research Institute fCampbell Family Mental Health Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YCO.0000000000000324DOI Listing
May 2017

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Brain 2017 May;140(5):1371-1383

Clinical Genetics Research Program and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awx053DOI Listing
May 2017

Internet Safety Issues for Adolescents and Adults with Intellectual Disabilities.

J Appl Res Intellect Disabil 2017 Mar 23;30(2):416-418. Epub 2016 Feb 23.

The Dalglish Family 22q Clinic, Toronto General Hospital, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jar.12250DOI Listing
March 2017

Obesity in adults with 22q11.2 deletion syndrome.

Genet Med 2017 02 18;19(2):204-208. Epub 2016 Aug 18.

Clinical Genetics Research Program and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2016.98DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292049PMC
February 2017

Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.

Psychiatr Genet 2016 12;26(6):229-257

aNeurogenetics Section bCampbell Family Mental Health Research Institute cClinical Genetics Research Program dKrembil Family Epigenetics Laboratory, Centre for Addiction and Mental Health eDepartment of Psychiatry fInstitute of Medical Science gDepartment of Psychology, University of Toronto hFrederick W. Thompson Anxiety Disorders Centre, Department of Psychiatry, Sunnybrook Health Sciences Centre iThe Dalglish Family 22q Clinic jUniversity Health Network kThe Centre for Applied Genomics, Genetics and Genome Biology, The Hospital for Sick Children, Toronto lMolecular Genetics Unit mBiomedical Sciences Division, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada nMax Planck Institute of Psychiatry oInstitute of Psychiatric Phenomics and Genomics, University of Munich, Munich pDepartment of Translational Research in Psychiatry, Institute of Computational Biology, Helmholtz Zentrum München qDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg rCharité Universitätsmedizin Berlin, Berlin, Germany sDepartment of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary tSchool of Social Work uDepartment of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan vStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, New York wDepartment of Psychiatry, University of Iowa, Iowa City, Iowa xVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia yDepartment of Chemistry and Biochemistry zDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California, USA †Department of Nuclear Medicine, Academic Medical Centre, Amsterdam, The Netherlands ‡Institute and Department of Psychiatry, University of São Paulo Medical School, São Paulo §Department of Genetics, Instituto de Biociências ¶ADHD Outpatient Clinic, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil ∥Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden #Department of Psychiatry, University of Calabar Teaching Hospital, Calabar, Nigeria **Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland ††Department of Psychiatry, Hakkari State Hospital, Turkey ‡‡Department of Genetics, University of Delhi, South Campus, New Delhi §§Molecular Genetics Lab, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India ¶¶Genetics Unit, IRCCS Centro S. Giovanni di Dio, Fatebenefratelli, Brescia, Italy ∥∥Queensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia ##Clinic for Psychiatry, Clinical Center of Serbia, Belgrade, Serbia ***Molecular Psychiatric Laboratory, Division of Psychiatry, University College London, London, UK †††Department of Clinical Medicine, Aarhus University, Aarhus ‡‡‡Psychosis Research Unit, Aarhus University Hospital, Risskov, Denmark §§§Human Genetics Lab, Department of Genetics ¶¶¶Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa ∥∥∥Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece ###Nagoya University, Nagoya, Japan ****School of Psychology, Shaanxi Normal University, Xi'an, China ††††School of Psychology, National University of Ireland, Galway, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YPG.0000000000000148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134913PMC
December 2016

Corrigendum to "Cardiac sympathetic activity in 22q11.2 deletion syndrome" [Int. J. Cardiol. 212 (2016) 346-351].

Int J Cardiol 2016 11 30;222:1141. Epub 2016 Jun 30.

Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.06.055DOI Listing
November 2016

Cardiac sympathetic activity in 22q11.2 deletion syndrome.

Int J Cardiol 2016 Jun 25;212:346-51. Epub 2016 Mar 25.

Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2016.03.185DOI Listing
June 2016

PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

Psychopharmacology (Berl) 2015 Sep 12;232(17):3111-22. Epub 2015 Jun 12.

Arkin Mental Health Care, Baron G.A. Tindalstraat 27, 1019 TS, Amsterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-015-3971-5DOI Listing
September 2015

Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Genet Med 2015 Aug 8;17(8):599-609. Epub 2015 Jan 8.

1] The Dalglish Family Hearts and Minds Clinic for 22q11.2 Deletion Syndrome, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada [2] Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [3] Department of Psychiatry and Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada [4] Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada [5] Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada [6] Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada [7] Division of Cardiology, Department of Medicine, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2014.175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526275PMC
August 2015

Parkinsonism in phenylketonuria: a consequence of dopamine depletion?

JIMD Rep 2015 23;20:35-8. Epub 2015 Jan 23.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/8904_2014_386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375126PMC
March 2015

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.

Am J Med Genet A 2015 Mar 13;167A(3):639-45. Epub 2015 Feb 13.

The Dalglish Family Hearts and Minds Clinic for Adults with 22q11.2 Deletion Syndrome, Toronto, Ontario, Canada; Department of Nuclear Medicine, Academic Medical Centre, Amsterdam, The Netherlands; Department of Psychiatry, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.36928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459830PMC
March 2015

Functional analysis of novel genetic variation in the thyroid hormone activating type 2 deiodinase.

J Clin Endocrinol Metab 2014 Nov 20;99(11):E2429-36. Epub 2014 Aug 20.

Department of Internal Medicine (C.Z., W.K., R.P.P., M.M., Y.B.d.R., M.E.M., T.J.V., W.E.V.), Rotterdam Thyroid Center (C.Z., W.K., R.P.P., M.M., M.E.M., T.J.V., W.E.V.), Department of Clinical Chemistry (Y.B.d.R.), Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands; Prinsenstichting (S.A.H.), Kwadijkerpark 8, 1444 JE Purmerend, The Netherlands; Ipse De Bruggen (H.G., E.B.), Spoorlaan 19, 2471 PB Zwammerdam, The Netherlands; Vanboeijenoord (G.d.K.), Industrieweg 14-16, 9400 RA Assen, The Netherlands; 's Heeren Loo Groot Schuilenburg (K.H.d.W.), Laan Van Groot Schuylenburg 310-320, 7325 BG Apeldoorn, The Netherlands; and Department of Internal Medicine (R.L.), Brigham and Women's Hospital, Boston, Massachusetts 02115.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-2281DOI Listing
November 2014

Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.

Int J Neuropsychopharmacol 2014 Aug 8;17(8):1159-65. Epub 2014 Apr 8.

Department of Psychiatry and Psychology,School for Mental Health and Neuroscience MHeNS, Maastricht University Medical Centre,Maastricht,The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1461145714000376DOI Listing
August 2014

Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects.

EJNMMI Res 2011 Dec 16;1(1):37. Epub 2011 Dec 16.

Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2191-219X-1-37DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265412PMC
December 2011

White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia.

Schizophr Res 2011 Oct 9;132(1):75-83. Epub 2011 Aug 9.

Department of Psychiatry, Academic Medical Centre Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.07.017DOI Listing
October 2011

COMT Val(158) met genotype and striatal D(2/3) receptor binding in adults with 22q11 deletion syndrome.

Synapse 2011 Sep 26;65(9):967-70. Epub 2011 Apr 26.

Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20932DOI Listing
September 2011

Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.

Clin Nucl Med 2011 Feb;36(2):148-9

Department of Nuclear Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e318203be54DOI Listing
February 2011

AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.

Eur J Nucl Med Mol Imaging 2008 Jul 19;35(7):1350-6. Epub 2008 Feb 19.

Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Meibergdreef 5, 1070 AW Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-008-0739-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440966PMC
July 2008

Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome.

Neuropsychopharmacology 2008 May 25;33(6):1252-8. Epub 2007 Jul 25.

Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1301508
Publisher Site
http://dx.doi.org/10.1038/sj.npp.1301508DOI Listing
May 2008